ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01197378
Recruitment Status : Completed
First Posted : September 9, 2010
Last Update Posted : July 18, 2017
Sponsor:
Information provided by (Responsible Party):
Horizon Pharma USA, Inc.